NLS merger partner Kadimastem secures Hong Kong patent for diabetes therapy

Investing.comThursday, September 4, 2025 at 11:44:48 AM
Kadimastem has successfully secured a patent in Hong Kong for its innovative diabetes therapy, marking a significant milestone in its efforts to combat the disease.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended apps based on your readingExplore all apps